Creo Medical Group (AIM:CREO) said SpydrBlade Flex was used by Professor Christopher C. Thompson MD to complete two BEAM procedures that he presented at Frontiers in Endoscopic Surgery (FES) 2026.
The company, a medical device group focused on advanced energy for therapeutic endoscopy, says the procedures demonstrate the device’s ability to perform precise full‑thickness antral myotomy in complex submucosal environments.
"SpydrBlade Flex is a gamechanger for the myotomy and provides a high level of precision and control during these steps," Professor Thompson said.
SpydrBlade Flex is powered by Creo’s CROMA™ Advanced Energy Platform, which delivers adaptive bipolar radiofrequency and microwave energy to enable controlled cutting, dissection and haemostasis.
BEAM adapts third‑space endoscopy to selectively target the gastric antrum with the aim of reducing contractility and delaying gastric emptying to promote long‑term satiety and weight loss.
Creo said the cases reinforce SpydrBlade Flex as a core component of its advanced GI portfolio and support its strategy to expand platform utilisation by broadening clinical applications through partnerships with leading innovators.
